ACCEPTED MANUSCRIPT
Table 3. Comparison of the M•••M distances of hetero- and homodinuclear complexes 2‒4 with well known structurally characterized dinuclear
models.
dinuclear models
dinuclear complexes [ref]
M•••M (Å)
3.459(12)
3.437(1)
3.7030(7)
3.415(12)
3.421
II
III
[
Zn(II)Fe(III)]
{L[Zn (–OAc) Fe ]}(BPh ) (2) [our work]
2
4 2
[
FeZnBPMP(OAc) ](BPh ) [106]
2
4 2
II
III
[
Zn Fe BPMOP{O P(OPh) } ](ClO ) [44]
2
2
2
4 2
1
II
III
{
L [Zn (μ-OAc) Fe ]}(ClO ) [94]
2
4 2
II
III
[
[
[
Zn Fe (BMMHP)(CH COO) ](BPh ) [52]
3 2 4
II
III
Zn Fe (IPCPMP)(OAc) (CH OH)][PF ] [76, 78]
3.4556(6)
3.490(9)
2
3
6
II
III
Zn Fe (BPBPMP)(OAc) ]ClO [69]
2
4
II
II
[
Zn(II)Zn(II)]
{L[Zn (–OAc) Zn ]}(BPh ) (3) [our work]
3.337(11)
3.3714(4)
3.0696(13)
3.5513(7)
3.465(5)
2
4 2
[
[
[
[
[
[
Zn (BPMP)(OAc) ]PF [59]
2 2 6
2
Zn L OH] [107]
2
2
Zn L (CH OH) ](ClO ) [108]
2
3
3
4
Zn (TPDP)(OAc)](ClO ) [58]
2
4 2
3
Zn (CH L )-(CH COO) ]BPh [75]
3.2391(6)
3.3689(14)
2
3
3
2
4
II
4
Zn (L )(μ-O CMe) (MeCN) ][BPh ] [40]
2
2
2
2
4
II
II
[
Ni(II)Ni(II)]
{L[Ni (–OAc) Ni ]}(BPh ) (4) [our work]
3.3853(4)
3.434(1)
3.4131(5)
3.486(1)
3.431(1)
3.396(2)
2
4 2
[
[
[
[
[
Ni (OAc) (AA)(urea)(tmen) ][OTf] [109]
2 2 2
Cl
Ni (μ-L O)(μ -OAc) ](PF ) [100]
2
2
2
6
5
Ni (L )(OAc) (CH CN)]BPh [110]
2
2
3
4
6
Ni (L )(OAc) (CH CN)]BPh [110]
2
2
3
4
‒
Ni (BCIMP)Ac ] [111]
2
2
bioactive enzymes
Red kidney bean PAP (Fe•••Zn) [27]
mammalian PAP (Fe•••Zn) [23]
3.1
3.31
3
.4
zinc phosphoesterase (isolated from Pseudomonas diminuta bacteria) (Zn•••Zn) [32]
Where as, HBPMP = 2,6-bis[(bis(2-pyridylmethyl)amino)methyl)]-4-methylphenol; HBPMOP = 2,6-bis[{bis(2-pyridylmethyl)amino}methyl]-
-methoxyphenol; BMMHP 2-{[bis(2-methoxyethyl)-amino]methyl}-6-{[(2-hydroxybenzyl)(2-pyridylmethyl)amino]-methyl}-4-
methylphenol; IPCPMP = 2-(N-isopropyl-N-((2-pyridyl)methyl)aminomethyl)-6-(N-(carboxylmethyl)-N-((2-pyridyl)methyl)aminomethyl)-4-
4
=
1
methylphenol; HL
=
2-{[bis(2-methylpyridyl)-amino]methyl}-6-{[((1-methylimidazol-2-yl)methyl)(2-pyridylmethyl)amino]methyl}-4-t-
butylphenol; H BPBPMP = 2-bis[{(2-pyridylmethyl)-aminomethyl}-6-{(2-hydroxybenzyl)(2-pyridylmethyl)}-aminomethyl]-4-methylphenol;
2
2
H L = 2,6-bis{[(2-hydroxybenzyl)(2-pyridylmethyl)amino]methyl]-4-methylphenol); HTPDP = 1,3-bis(bis-pyridin-2-ylmethylamino)propan-2-
3
3
ol; CH L = 2-(((2-methoxyethyl)(pyridine-2-ylmethyl)-amino)methyl)-4-methyl-6-(((pyridin-2-ylmethyl)(4-vinylbenzyl)-amino)methyl)phenol;
3
4
H3L = 2,6-bis((hydroxyethyl)(methoxyethyl)-aminomethyl)-4-methylphenol; AA= acetohydroxamate anion; tmen = N,N,N′,N′-
5
Cl
tetramethylethylenediamine; L = 2-[N-bis-(2-pyridylmethyl)aminomethyl]-4-methyl-6-[N-(2-pyridylmethyl)aminomethyl]phenolate); L -OH =
6
2
,6-bis[bis(2-pyridylmethyl)aminomethyl]-4-chlorophenol;
L
=
2-[N-bis-(2-pyridylmethyl)aminomethyl]-4-methyl-6-[N-(2-
pyridylmethyl)aminomethyl]phenolate);
methylphenolate
BCIMP
=
2,6-bis[N-(N-(carboxylmethyl)-N-((1-methylimidazolyl)methyl)amine)methyl]-4-
1
5